Perioperative use of Perioperative use of RAAS Antagonists: RAAS Antagonists: Evidence and Controversy Evidence and Controversy Moises Auron MD, FAAP Moises Auron MD, FAAP Department of Hospital Department of Hospital Medicine Medicine Cleveland Clinic Cleveland Clinic
46
Embed
Perioperative Use of Renin-Angiotensin-Aldosterone System Antagonists
The clinician find a difficulty in deciding whether to continue or not the Renin-Angiotensin-Aldosterone Antagonists perioperatively. The evidence supporting and against its use is presented. The clinician is advised about considering Aliskiren in the same context of RAAS antagonists.
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Perioperative use of RAAS Perioperative use of RAAS Antagonists: Evidence and Antagonists: Evidence and
ControversyControversy
Moises Auron MD, FAAPMoises Auron MD, FAAP
Department of Hospital MedicineDepartment of Hospital Medicine
• Appraise the evidence supporting the current perioperative management of Renin-Angiotensin-Aldosterone system (RAAS) antagonists in non-cardiac surgery.
• Appraise the existence of newer RAAS antagonists such as Aliskiren (direct renin inhibitor) and its management in the perioperative setting.
• Current practice: discontinue both ACEI and ARB on the morning of surgery.
• Based on several small, controlled, randomized studies which found an increased frequency of refractory hypotension requiring intensive intravenous fluids and vasopressors after the induction of anesthesia when RAAS-antagonists were not discontinued preoperatively.
Brabant• Hemodynamic response to induction between
ARB, beta-blockers (BB), Ca channel blockers (CB) and ACEI.
• ↓BP : SBP ↓ of > 30% from the preoperative value or an absolute SBP < 90 mm Hg. – ARB (12 of 12)– BB/CB-treated patients (27 of 45)– ACEI (18 of 27) (P< 0.05).
• ARB group – increased refractory to adrenergic agents (4 of 12) vs. BB/CB group (0 of 45) vs. ACEI (1 of 27).
• Patients on chronic anti-HTN treatment with ACEI/ARB (N = 267)
• Incidence of ↓BP during the first 30 minutes after induction of anesthesia was more frequent in patients whose most recent ACEI/ARB was taken < 10 h. (60% vs. 46%, O.R. 1.74 (95% C.I. 1.03 to 2.93, P = 0.04)
• Heropoulos– Assessment of hemodynamic and hormonal responses to:
• ETI• Incision• Limb-tourniquet inflation
– RCT; N = 30 patients undergoing limb surgery – Enalaprilat vs. placebo.
• - 1.25 mg IV 20 min prior to induction vs. 0.625 mg IV at the onset of tourniquet-associated hypertension.
– Venous blood samples for PRA and catecholamine (pre-intubation, 3 min post-intubation, 3 min post-incision, at onset of tourniquet hypertension, 3 min post-extubation and 1 hr postoperatively)
• No significant differences in catecholamine levels.
• Pre-operative enalapril in balanced hypotensive anesthesia for cerebrovascular surgery.
• Controlled ↓BP - minimize intraoperative bleeding. RCT vs. placebo.
• Enalapril ↓ HTN response to ETI, ↓ postoperative vasodilators, more stable BP control.
• “Preoperative fasting may be the contributor to peri-operative ↓BP - improper fluid balance and Na2+ depletion - prevented by ensuring proper intravascular volume status”
• Effect of pre-op ACEI on AKI (↓GFR > 50%) – CABG.
• Preop ACEI (N = 281) - ↓ post-op AKI (O.R. 0.48; 95% CI, 0.23 to 0.77; P < 0.04)
• Incidence of AKI requiring dialysis:– 2.4% in ACEI group vs. 6.3% in controls (P =
0.03). (44)
Ann Thorac Surg. 2008 Oct;86(4):1160-5.
Cittanova
• Prospective study (N = 249) - aortic surgery
• Chronic treatment with ACEI (withheld in AM) - only factor associated with significative postoperative renal impairment (O.R. 2.01 95% C.I. 1.05 to 3.83)
Anesth Analg. 2001 Nov;93(5):1111-5.
Kincaid
• Retrospective (N= 1209) – CABG
• Preop ACEI along with intra-op aprotinin – ARF (OR 2.9, 95% CI 1.4 to 5.8, P < 0.0001).
• Hohne– Assessment of the initial (first 20 minutes)
hemodynamic effect of ACEI in spinal anesthesia for lower body procedures.
– RCT (21 on chronic ACEI vs. 21 control)– Decrease in BP was similar.– Plasma vasopressin and norepinephrine
levels increased.
Acta Anaesthesiol Scand. 2003 Aug;47(7):891-6.
Aliskiren
• Direct renin inhibitor
• Long half life (30 - 40h)
• Increased renal vasodilatory effect vs. ACEI and ARB. (59)
• Low oral bioavailability– Terminal half life is 24 hrs.
• Weak antihypertensive (second-line agent)
J Am Coll Cardiol. 2008 Feb 5;51(5):519-28.Circulation. 2008 Aug 12;118(7):773-84.Am J Health Syst Pharm. 2008 Jul 15;65(14):1323-32.
Conclusions
• RAAS-antagonists - associated with a variable incidence of hypotension during the initial 30 minutes after induction of anesthesia in non-cardiac surgery
• These hypotensive episodes have not been linked to any significant postoperative complications.
• The ACEI/ARB should be held at least 10 hours or for one dose before the induction of anesthesia.
Conclusions (cont.)
• Careful hemodynamic monitoring
• Prevention of hypovolemia
• When to continue RAAS-antagonists?– Complicated hypertensive patient– Chronic heart failure of ischemic heart
disease– Cardiac surgery– Requires discussion with anesthesiologist